Milton & Ethel Warner Dialysis Unit - Spencer is a medicare approved dialysis facility center in Spencer, Iowa and it has 8 dialysis stations. It is located in Clay county at 1200 First Ave East, Spencer, IA, 51301. You can reach out to the office of Milton & Ethel Warner Dialysis Unit - Spencer at (712) 264-6464. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Milton & Ethel Warner Dialysis Unit - Spencer has the following ownership type - Non-Profit. It was first certified by medicare in September, 1994. The medicare id for this facility is 160112 and it accepts patients under medicare ESRD program.
| Name | Milton & Ethel Warner Dialysis Unit - Spencer |
|---|---|
| Location | 1200 First Ave East, Spencer, Iowa |
| No. of Dialysis Stations | 8 |
| Medicare ID | 160112 |
| Managed By | Independent |
| Ownership Type | Non-Profit |
| Late Shifts | No |
| 1200 First Ave East, Spencer, Iowa, 51301 | |
| (712) 264-6464 | |
News Archive
Many preventive measures for cognitive decline and for preventing Alzheimer's disease-mental stimulation, exercise, and a variety of dietary supplements-have been studied over the years. However, an independent panel convened this week by the National Institutes of Health determined that the value of these strategies for delaying the onset and/or reducing the severity of decline or disease hasn't been demonstrated in rigorous studies.
An international team of sleep researchers has developed the world's first screening tool to help reduce workplace accidents and illnesses, including cardiovascular disease and cancer, caused by shift work.
Black people are more likely to lose vision as a result of idiopathic intracranial hypertension, or increased pressure in the brain, according to a study published in the March 11, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.
Three studies being presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La., highlight the breadth of research propelling advances in clinical cardiology.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.
› Verified 6 days ago
| NPI Number | 1578550893 |
| Organization Name | Warner Dialysis Center Spencer |
| Doing Business As | Spencer Municipal Hospital |
| Address | 1200 1st Ave E Spencer, Iowa, 51301 |
| Phone Number | (712) 264-6111 |
News Archive
Many preventive measures for cognitive decline and for preventing Alzheimer's disease-mental stimulation, exercise, and a variety of dietary supplements-have been studied over the years. However, an independent panel convened this week by the National Institutes of Health determined that the value of these strategies for delaying the onset and/or reducing the severity of decline or disease hasn't been demonstrated in rigorous studies.
An international team of sleep researchers has developed the world's first screening tool to help reduce workplace accidents and illnesses, including cardiovascular disease and cancer, caused by shift work.
Black people are more likely to lose vision as a result of idiopathic intracranial hypertension, or increased pressure in the brain, according to a study published in the March 11, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.
Three studies being presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La., highlight the breadth of research propelling advances in clinical cardiology.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 13 |
News Archive
Many preventive measures for cognitive decline and for preventing Alzheimer's disease-mental stimulation, exercise, and a variety of dietary supplements-have been studied over the years. However, an independent panel convened this week by the National Institutes of Health determined that the value of these strategies for delaying the onset and/or reducing the severity of decline or disease hasn't been demonstrated in rigorous studies.
An international team of sleep researchers has developed the world's first screening tool to help reduce workplace accidents and illnesses, including cardiovascular disease and cancer, caused by shift work.
Black people are more likely to lose vision as a result of idiopathic intracranial hypertension, or increased pressure in the brain, according to a study published in the March 11, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.
Three studies being presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La., highlight the breadth of research propelling advances in clinical cardiology.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 17 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 154 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Many preventive measures for cognitive decline and for preventing Alzheimer's disease-mental stimulation, exercise, and a variety of dietary supplements-have been studied over the years. However, an independent panel convened this week by the National Institutes of Health determined that the value of these strategies for delaying the onset and/or reducing the severity of decline or disease hasn't been demonstrated in rigorous studies.
An international team of sleep researchers has developed the world's first screening tool to help reduce workplace accidents and illnesses, including cardiovascular disease and cancer, caused by shift work.
Black people are more likely to lose vision as a result of idiopathic intracranial hypertension, or increased pressure in the brain, according to a study published in the March 11, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.
Three studies being presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La., highlight the breadth of research propelling advances in clinical cardiology.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Milton & Ethel Warner Dialysis Unit - Spencer with elevated calcium levels.
| Patients with hypercalcemia | 18 |
| Hypercalcemia patient months | 166 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 3 |
| Patients with Serumphosphor | 19 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 43 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 27 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 10 |
| Patients with Serumphosphor greater than 7 mg/dL | 10 |
News Archive
Many preventive measures for cognitive decline and for preventing Alzheimer's disease-mental stimulation, exercise, and a variety of dietary supplements-have been studied over the years. However, an independent panel convened this week by the National Institutes of Health determined that the value of these strategies for delaying the onset and/or reducing the severity of decline or disease hasn't been demonstrated in rigorous studies.
An international team of sleep researchers has developed the world's first screening tool to help reduce workplace accidents and illnesses, including cardiovascular disease and cancer, caused by shift work.
Black people are more likely to lose vision as a result of idiopathic intracranial hypertension, or increased pressure in the brain, according to a study published in the March 11, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.
Three studies being presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La., highlight the breadth of research propelling advances in clinical cardiology.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 18 |
| Patient months included in arterial venous fistula and catheter summaries | 149 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 72 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 19 |
News Archive
Many preventive measures for cognitive decline and for preventing Alzheimer's disease-mental stimulation, exercise, and a variety of dietary supplements-have been studied over the years. However, an independent panel convened this week by the National Institutes of Health determined that the value of these strategies for delaying the onset and/or reducing the severity of decline or disease hasn't been demonstrated in rigorous studies.
An international team of sleep researchers has developed the world's first screening tool to help reduce workplace accidents and illnesses, including cardiovascular disease and cancer, caused by shift work.
Black people are more likely to lose vision as a result of idiopathic intracranial hypertension, or increased pressure in the brain, according to a study published in the March 11, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.
Three studies being presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La., highlight the breadth of research propelling advances in clinical cardiology.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 22 |
| Hospitalization Rate in facility | 141.4 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 337.5 |
| Hospitalization Rate: Lower Confidence Limit | 63.4 |
News Archive
Many preventive measures for cognitive decline and for preventing Alzheimer's disease-mental stimulation, exercise, and a variety of dietary supplements-have been studied over the years. However, an independent panel convened this week by the National Institutes of Health determined that the value of these strategies for delaying the onset and/or reducing the severity of decline or disease hasn't been demonstrated in rigorous studies.
An international team of sleep researchers has developed the world's first screening tool to help reduce workplace accidents and illnesses, including cardiovascular disease and cancer, caused by shift work.
Black people are more likely to lose vision as a result of idiopathic intracranial hypertension, or increased pressure in the brain, according to a study published in the March 11, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.
Three studies being presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La., highlight the breadth of research propelling advances in clinical cardiology.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at Milton & Ethel Warner Dialysis Unit - Spencer were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 15.5 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 34 |
| Readmission Rate: Lower Confidence Limit | 4.7 |
News Archive
Many preventive measures for cognitive decline and for preventing Alzheimer's disease-mental stimulation, exercise, and a variety of dietary supplements-have been studied over the years. However, an independent panel convened this week by the National Institutes of Health determined that the value of these strategies for delaying the onset and/or reducing the severity of decline or disease hasn't been demonstrated in rigorous studies.
An international team of sleep researchers has developed the world's first screening tool to help reduce workplace accidents and illnesses, including cardiovascular disease and cancer, caused by shift work.
Black people are more likely to lose vision as a result of idiopathic intracranial hypertension, or increased pressure in the brain, according to a study published in the March 11, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.
Three studies being presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La., highlight the breadth of research propelling advances in clinical cardiology.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.
› Verified 6 days ago